RecruitingNot applicableNCT05570591
Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy
Studying Central serous chorioretinopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Nova Eye Medical Pty Ltd.
- Principal Investigator
- Mali Okada, MBBS FRANZCOCenter for Eye Research Australia
- Intervention
- 2RT subthreshold nanosecond laser - active(device)
- Enrollment
- 60 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2022 – 2024
Study locations (2)
- Centre for Eye Research Australia, East Melbourne, Victoria, Australia
- Retinology Institute, Glen Iris, Victoria, Australia
Collaborators
Center for Eye Research Australia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05570591 on ClinicalTrials.govOther trials for Central serous chorioretinopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06527326the Study of the Association Between the Gut Microbiota and Central Serous ChorioretinopathySecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGNCT06346405Central Serous Chorioretinopathy and Micropulse Laser TreatmentFondazione Policlinico Universitario Agostino Gemelli IRCCS
- RECRUITINGNCT05589974Choroidal Blood Flow in Acute and Chronic Central Serous ChorioretinopathyHelse Stavanger HF